Spots Global Cancer Trial Database for 18F-Fluorodeoxyglucose Positron Emission Tomography in Oncology and Neurology
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: 18F-Fluorodeoxyglucose Positron Emission Tomography in Oncology and Neurology
Official Title: 18F-Fluorodeoxyglucose Positron Emission Tomography in Oncology and Neurology
Study ID: NCT01180751
Conditions
Interventions
Study Description
Brief Summary: This clinical trial is being conducted to study the use of a radioactive glucose tracer as an imaging test \[Positron Emission Tomography (PET)scan\] in adults who have or are suspected of having cancer and in another group of adults to assess for neurologic conditions.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Great West Life PET/CT Centre, Winnipeg, Manitoba, Canada
Contact Details
Name: Daniel P Levin, BSc,MD,FRCPC
Affiliation: Winnipeg Regional Health Authority
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
